Strength: 50mg
Indications:
1) 50mg daily: combination with luteinizing hormone releasing hormone (LHRH) analogue or surgical orchectomy for the treatment of advanced prostate cancer.
2) 150mg daily: for the treatment of locally advanced prostate cancer without distant metastasis in patients who are not suitable or unwilling to undergo surgical castration or other medical treatment.
Copyright © 山西振东医药有限公司版权所有 | 网站地图 | 技术支持: